Provided by Tiger Trade Technology Pte. Ltd.

Capricor Therapeutics

9.36
+1.0712.91%
Pre-market: 9.410.0500+0.53%05:03 EDT
Volume:12.04M
Turnover:110.40M
Market Cap:544.18M
PE:-3.80
High:9.88
Open:8.29
Low:8.05
Close:8.29
52wk High:40.37
52wk Low:2.96
Shares:58.14M
Float Shares:45.54M
Volume Ratio:0.96
T/O Rate:26.43%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.4659
EPS(LYR):-2.2601
ROE:-73.70%
ROA:-33.63%
PB:2.21
PE(LYR):-4.14

Loading ...

Assessing Capricor Therapeutics (CAPR) Valuation After Strong Multi Year Gains And Recent Share Price Pullback

Simply Wall St.
·
May 14

Capricor Therapeutics Price Target Maintained With a $60.00/Share by HC Wainwright & Co.

Dow Jones
·
May 13

BRIEF-Capricor Therapeutics Reports First Quarter 2026 Financial Results

Reuters
·
May 13

Capricor Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 13

Capricor Therapeutics Q1 Loss Widens

MT Newswires Live
·
May 13

Capricor Q1 FY26 net loss widens to $33.9 million; revenue remains no revenue

Reuters
·
May 13

Capricor Therapeutics options imply 9.4% move in share price post-earnings

TIPRANKS
·
May 13

Capricor Therapeutics Q1 EPS $(0.59) Misses $(0.50) Estimate

Benzinga Earnings
·
May 13

Capricor Therapeutics Inc - No Revenue Recognized for Q1 2026 or Q1 2025

THOMSON REUTERS
·
May 13

Capricor Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update

THOMSON REUTERS
·
May 13

Capricor Therapeutics: Available Cash, Cash Equivalents, Marketable Securities Sufficient to Cover Expenses & Capital Requirements Through Q4 2027

THOMSON REUTERS
·
May 13

Analysts Offer Insights on Healthcare Companies: ImageneBio (IMA) and Capricor Therapeutics (CAPR)

TIPRANKS
·
May 11

Capricor files suit against NS Pharma over Deramiocel distribution deal

TIPRANKS
·
May 09

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Capricor Therapeutics (CAPR), Enovis (ENOV) and Progyny (PGNY)

TIPRANKS
·
May 09

Capricor Therapeutics Says NS Pharma Delays Could Threaten Access To Duchenne Therapy

Benzinga
·
May 08

H.C. Wainwright Sticks to Its Buy Rating for Capricor Therapeutics (CAPR)

TIPRANKS
·
May 08

Capricor sues Nippon Shinyaku over US distribution rights for CAP-1002

Reuters
·
May 08

Capricor Therapeutics Inc - Alleges Ns Pharma Failed to Prepare for Deramiocel Launch and Breached Agreement - SEC Filing

THOMSON REUTERS
·
May 08

Capricor Therapeutics Inc - Files Lawsuit and Seeks Preliminary Injunction in New Jersey Court on May 7, 2026 - SEC Filing

THOMSON REUTERS
·
May 08

Earning Preview: Capricor Therapeutics this quarter’s revenue is expected to decrease by 100%, and institutional views are bullish

Earnings Agent
·
May 06